Committee Print Regarding Patent Quality Improvement: Hearing Before the Subcommittee on Courts, the Internet, and Intellectual Property of the Committee on the Judiciary, House of Representatives, One Hundred Ninth Congress, First Session, April 20 and April 28, 2005U.S. Government Printing Office, 2005 - 206 lappuses |
No grāmatas satura
1.5. rezultāts no 20.
. lappuse
... Genentech Oral Testimony Prepared Statement Mr. William L. LaFuze , Partner , Vinson & Elkins , LLP , and Chair , Section of Intellectual Property Law , American Bar Association , on behalf of the American Bar Association and the ABA ...
... Genentech Oral Testimony Prepared Statement Mr. William L. LaFuze , Partner , Vinson & Elkins , LLP , and Chair , Section of Intellectual Property Law , American Bar Association , on behalf of the American Bar Association and the ABA ...
5. lappuse
... Kushan , a Partner and Patent Attor- ney at Sidley , Austin Brown and Wood's Washington , D.C. office . He is testifying on behalf of Genentech , a biotechnology company based in San Francisco . Mr. Kushan is a graduate 5.
... Kushan , a Partner and Patent Attor- ney at Sidley , Austin Brown and Wood's Washington , D.C. office . He is testifying on behalf of Genentech , a biotechnology company based in San Francisco . Mr. Kushan is a graduate 5.
24. lappuse
... Genentech , a biotech company based in south San Fran- cisco , California . Genentech appreciates the opportunity to provide its views to you on the issue of patent law reform . We commend you , Mr. Chairman , along with Mr. Berman and ...
... Genentech , a biotech company based in south San Fran- cisco , California . Genentech appreciates the opportunity to provide its views to you on the issue of patent law reform . We commend you , Mr. Chairman , along with Mr. Berman and ...
25. lappuse
... Genentech's Avastin product . This product was the product development effort for this product start- ed in 1989. Avastin was approved in 2004. That's 15 years of effort ind hundreds of millions of dollars of cost to getting this ...
... Genentech's Avastin product . This product was the product development effort for this product start- ed in 1989. Avastin was approved in 2004. That's 15 years of effort ind hundreds of millions of dollars of cost to getting this ...
26. lappuse
... Genentech believes the system proposed in the committee print is a good start . However , several changes are needed to make this a more balanced and effective procedure , and we invite the Subcommittee to review our written testimony ...
... Genentech believes the system proposed in the committee print is a good start . However , several changes are needed to make this a more balanced and effective procedure , and we invite the Subcommittee to review our written testimony ...
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
accused infringer American Bar Association areas BERMAN best mode biotechnology business method patents Chairman challenge changes Committee Print companies Congress defense disclosure effective elimination ensure Federal Circuit Genentech GOODLATTE grant important improve inequitable conduct innovation inter partes reexamination interference proceedings invalid invention date inventor to file Kushan legislation limited Markman hearings NRC recommendation NRC report opposition proceeding Patent and Trademark patent applications patent claims patent examiner patent infringement patent interference patent litigation Patent Office patent owner patent quality patent reform patent validity patented invention permanent injunction post-grant opposition system post-grant review prior art problem proposed quality patents requirement right to patent Section agrees Section supports SMITH standard Subcommittee subject matter Thank third parties tion Trademark Office treble damages U.S. patent law U.S. patent system unenforceable United States Patent USPTO valid patent
Populāri fragmenti
81. lappuse - Its purpose is to encourage full and frank communication between attorneys and their clients and thereby promote broader public interests in the observance of law and administration of justice.
77. lappuse - Party may provide limited exceptions to the exclusive rights conferred by a patent, provided that such exceptions do not unreasonably conflict with a normal exploitation of the patent and do not unreasonably prejudice the legitimate interests of the patent owner, taking into account the legitimate interests of other persons.
122. lappuse - Congress shall have the power .... to promote the progress of science, and the useful arts, by securing for limited times to authors and inventors, the exclusive right to their respective writings and discoveries.
27. lappuse - I am a partner in the Washington office of the law firm of Sidley Austin Brown and Wood, LLP.
91. lappuse - Cir., 246 F. 695. Such a forfeiture has nothing to do with abandonment, which presupposes a deliberate, though not necessarily an express, surrender of any right to a patent. Although the evidence of both may at times overlap, each comes from a quite different legal source : one, from the fact that by renouncing the right the inventor irrevocably surrenders it; the other, from the fiat of Congress that it is part of the consideration for a patent that the public shall as soon as possible begin to...
22. lappuse - The several courts vested with jurisdiction of cases arising under the patent laws shall have power to grant injunctions according to the course and principles of courts of equity, to prevent the violation of any right secured by patent, on such terms as the court may deem reasonable...
96. lappuse - Any State whose national law provides for prior art effect of its patents as from a date before publication, but does not equate for prior art purposes the priority date claimed under the Paris Convention for the Protection of Industrial Property to the actual filing date in that State, may declare that the filing outside that State of an international application designating that State is not equated to an actual filing in that State for prior art purposes.
152. lappuse - State St. Bank & Trust Co. v. Signature Fin. Group, Inc., 149 F.3d 1368 (Fed. Cir. 1998...
160. lappuse - The state of the art shall be held to comprise everything made available to the public by means of a written or oral description, by use, or in any other way, before the date of filing of the European patent application.
122. lappuse - Century Competitiveness, Committee on Education and the Workforce US House of Representatives "Welfare Reform: Success in Moving Toward Work" October 16, 2001 Mr. Chairman and Members of the Subcommittee: Thank you very much for inviting me to testify today.